Gastro-oesophageal reflux disease in Asia: Birth of a 'new' disease?

Drugs

Volumn 68, Issue 4, 2008, Pages 399-406

  Cheung, Ting K ^a   Wong, Benjamin C Y ^a   Lam, Shiu K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Ethnic groups; Gastro oesophageal reflux, treatment; Proton pump inhibitors, therapeutic use

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; ASIA; ASTHMA; BARRETT ESOPHAGUS; BODY WEIGHT; CHINA; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE ASSOCIATION; DISEASE COURSE; ENDOSCOPY; ETHNIC DIFFERENCE; FAT INTAKE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER PYLORI; HUMAN; LIFESTYLE MODIFICATION; NOTE; OBESITY; PALLIATIVE THERAPY; PATIENT ATTITUDE; PREVALENCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; SEX DIFFERENCE; SMOKING CESSATION; SMOKING HABIT; STOMACH FUNDOPLICATION; SYMPTOM; THORAX PAIN; TREATMENT OUTCOME; TREATMENT PLANNING;

ASIA; GASTROESOPHAGEAL REFLUX; HUMANS; TERMINOLOGY AS TOPIC;

EID: 40349113721     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200868040-00001     Document Type: Note

References (87)

1. Locke 3rd GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 May; 112 (5): 1448-56
2. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002 May; 122 (5): 1500-11
3. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management: the Genval Workshop Report. Gut 1999 Apr; 44 Suppl. 2: S1-16
4. Fock KM, Talley N, Hunt R, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol 2004 Apr; 19 (4): 357-67
5. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006 Aug; 101 (8): 1900-20
6. Wong WM, Hui WM, Wong BC. Asia-Pacific consensus on gastroesophageal reflux disease. J Gastroenterol Hepatol 2004 Apr; 19 (4): 353-6
7. Goh KL, Chang CS, Fock KM, et al. Gastro-oesophageal reflux disease in Asia. J Gastroenterol Hepatol 2000 Mar; 15 (3): 230-8
8. Locke GR, Talley NJ, Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994 Jun; 69 (6): 539-47
9. Wong WM, Lam KF, Lai KC, et al. A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese population. Aliment Pharmacol Ther 2003 Jun 1; 17 (11): 1407-13
10. Spechler SJ, Jain SK, Tendler DA, et al. Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002 Oct; 16 (10): 1795-800
11. Ho KY, Ng WL, Kang JY, et al. Gastroesophageal reflux disease is a common cause of noncardiac chest pain in a country with a low prevalence of reflux esophagitis. Dig Dis Sci 1998 Sep; 43 (9): 1991-7
12. Wong WM, Lai KC, Lau CP, et al. Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest pain. Aliment Pharmacol Ther 2002 Mar; 16 (3): 465-71
13. Wong WM, Lai KC, Lam KF, et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther 2003 Sep 15; 18 (6): 595-604
14. Hill J, Stuart RC, Fung HK, et al. Gastroesophageal reflux, motility disorders, and psychological profiles in the etiology of globus pharyngis. Laryngoscope 1997 Oct; 107 (10): 1373-7
15. Nakase H, Itani T, Mimura J, et al. Relationship between asthma and gastro-oesophageal reflux: significance of endoscopic grade of reflux oesophagitis in adult asthmatics. J Gastroenterol Hepatol 1999 Jul; 14 (7): 715-22
16. Wong WM, Lai KC, Lam KF, et al. Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study. Aliment Pharmacol Ther 2004 Oct 1; 20 (7): 803-12
17. Wang JH, Luo JY, Dong L, et al. Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China. World J Gastroenterol 2004 Jun 1; 10 (11): 1647-51
18. Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol 2005 Jan; 20 (1): 26-9
19. Watanabe Y, Fujiwara Y, Shiba M, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol 2003 Aug; 38 (8): 807-11
20. Agreus L, Svardsudd K, Talley NJ, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001 Oct; 96 (10): 2905-14
21. Haque M, Wyeth JW, Stace NH, et al. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J 2000 May 26; 113 (1110): 178-81
22. Frank L, Kleinman L, Ganoczy D, et al. Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci 2000 Apr; 45 (4): 809-18
23. Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000 Dec; 14 (12): 1589-94
24. Hu WHC, Wong W-M, Lam CLK, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther 2002; 16 (12): 2081-8
25. Pan GZ, Xu GM, Ke MY, et al. Epidemiological study of symptomatic gastroesophageal reflux disease in China: Beijing and Shanghai. Chin J Dig Dis 2000; 1: 2-8
26. Chen M, Xiong L, Chen H, et al. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: a population-based study in South China. Scand J Gastroenterol 2005 Jul; 40 (7): 759-67
27. Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol 2005 Apr; 100 (4): 747-53
28. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006 Apr; 4 (4): 398-407
29. Wong WM, Lam SK, Hui WM, et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese: prevalence and spectrum of the disease. Aliment Pharmacol Ther 2002 Dec; 16 (12): 2037-42
30. Furukawa N, Iwakiri R, Koyama T, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol 1999 Aug; 34 (4): 441-4
31. Lee SJ, Song CW, Jeen YT, et al. Prevalence of endoscopic reflux esophagitis among Koreans. J Gastroenterol Hepatol 2001 Apr; 16 (4): 373-6
32. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig Dis Sci 2004 Feb; 49 (2): 237-42
33. Johansson KE, Ask P, Boeryd B, et al. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986 Sep; 21 (7): 837-47
34. Johnsson F, Joelsson B, Gudmundsson K, et al. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987 Aug; 22 (6): 714-8
35. Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997 Oct; 32 (10): 974-9
36. Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997 Aug; 11 (4): 765-73
37. Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998 Feb; 10 (2): 119-24
38. Robinson M, Earnest D, Rodriguez-Stanley S, et al. Heartburn requiring frequent antacid use may indicate significant illness. Arch Intern Med 1998 Nov 23; 158 (21): 2373-6
39. Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol 2004 May; 16 (5): 495-501
40. Wu JC, Chan FK, Ching JY, et al. Empirical treatment based on "typical" reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection. Gastrointest Endosc 2002 Apr; 55 (4): 461-5
41. Ang TL, Fock KM, Ng TM, et al. A comparison of the clinical, demographic and psychiatric profiles among patients with erosive and non-erosive reflux disease in a multi-ethnic Asian country. World J Gastroenterol 2005 Jun 21; 11 (23): 3558-61
42. Dent J, Dodds WJ, Friedman RH, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980 Feb; 65 (2): 256-67
43. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982 Dec 16; 307 (25): 1547-52
44. Mittal RK, Holloway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation. Gastroenterology 1995 Aug; 109 (2): 601-10
45. Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1988 Jan; 94 (1): 73-80
46. Holloway RH. Esophageal body motor response to reflux events: secondary peristalsis. Am J Med 2000 Mar 6; 108 Suppl 4a: 20-6S
47. Wong WM, Lai KC, Hui WM, et al. Pathophysiology of gastroesophageal reflux diseases in Chinese: role of transient lower esophageal sphincter relaxation and esophageal motor dysfunction. Am J Gastroenterol 2004 Nov; 99 (11): 2088-93
48. Ho KY, Cheung TK, Wong BC. Gastroesophageal reflux disease in Asian countries: disorder of nature or nurture? J Gastroenterol Hepatol 2006 Sep; 21 (9): 1362-5
49. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003 Mar; 38 Suppl. 15: 25-30
50. Lim SL, Goh WT, Lee JM, et al. Changing prevalence of gastroesophageal reflux with changing time: longitudinal study in an Asian population. J Gastroenterol Hepatol 2005 Jul; 20 (7): 995-1001
51. Wu JC, Sung JJ, Ng EK, et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol 1999 Jul; 94 (7): 1790-4
52. O'Connor HJ. Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management. Aliment Pharmacol Ther 1999 Feb; 13 (2): 117-27
53. Moayyedi P, Bardhan C, Young L, et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001 Nov; 121 (5): 1120-6
54. Wu JCY, Chan FKL, Ching JYL, et al. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 2004; 53 (2): 174-9
55. Wilson LJ, Ma W, Hirschowitz BI. Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol 1999 Oct; 94 (10): 2840-4
56. Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006 Jun 1; 354 (22): 2340-8
57. Holloway RH, Lyrenas E, Ireland A, et al. Effect of intraduodenal fat on lower oesophageal sphincter function and gastro-oesophageal reflux. Gut 1997 Apr; 40 (4): 449-53
58. Galmiche JP. Gastro-oesophageal reflux: does it matter what you eat? Gut 1998 Mar; 42 (3): 318-9
59. Richter JE. Extraesophageal presentations of gastroesophageal reflux disease: an overview. Am J Gastroenterol 2000 Aug; 95 (8 Suppl.): S1-3
60. Fennerty MB. Extraesophageal gastroesophageal reflux disease. Presentations and approach to treatment. Gastroenterol Clin North Am 1999 Dec; 28 (4): 861-73, vi
61. Tsugeno H, Mizuno M, Fujiki S, et al. A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux. Scand J Gastroenterol 2003 May; 38 (5): 456-61
62. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005 Jan; 100 (1): 190-200
63. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 2006 May 8; 166 (9): 965-71
64. Wani S, Sharma P. Review: sparse evidence supports lifestyle modifications for reducing symptoms of gastroesophageal reflux disease. ACP J Club 2006 Sep-Oct; 145 (2): 44
65. Weberg R, Berstad A. Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis. Scand J Gastroenterol 1989 May; 24 (4): 401-6
66. Breen KJ, Desmond PV, Whelan G. Treatment of reflux oesophagitis: a randomized, controlled evaluation of cimetidine. Med J Aust 1983 Nov 26; 2 (11): 555-8
67. Johansson KE, Boeryd B, Johansson K, et al. Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease. Scand J Gastroenterol 1986 Sep; 21 (7): 769-78
68. Palmer RH, Frank WO, Rockhold FW, et al. Cimetidine 800mg twice daily for healing erosions and ulcers in gastroesophageal reflux disease. J Clin Gastroenterol 1990; 12 Suppl. 2: S29-34
69. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988 Oct; 95 (4): 903-12
70. Cloud ML, Enas N, Humphries TJ, et al. Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group. Dig Dis Sci 1998 May; 43 (5): 993-1000
71. Earnest DL, Dorsch E, Jones J, et al. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis. Am J Gastroenterol 1998 Feb; 93 (2): 238-43
72. Richter JE, Bochenek W. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group. Am J Gastroenterol 2000 Nov; 95 (11): 3071-80
73. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet 2006 Jun 24; 367 (9528): 2086-100
74. Armstrong D, Pare P, Pericak D, et al. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. Am J Gastroenterol 2001 Oct; 96 (10): 2849-57
75. Bardhan KD, Hawkey CJ, Long RG, et al. Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group. Aliment Pharmacol Ther 1995 Apr; 9 (2): 145-51
76. Dehn TC, Shepherd HA, Colin-Jones D, et al. Double blind comparison of omeprazole (40mg od) versus cimetidine (400mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24h pH monitoring. Gut 1990 May; 31 (5): 509-13
77. Gillessen A, Beil W, Modlin IM, et al. 40mg pantoprazole and 40mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms. J Clin Gastroenterol 2004 Apr; 38 (4): 332-40
78. Vakil N. Review article: esomeprazole, 40mg once daily, compared with lansoprazole, 30mg once daily, in healing and symptom resolution of erosive oesophagitis. Aliment Pharmacol Ther 2003 Feb; 17 Suppl. 1: 21-3
79. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000 Apr; 118 (4): 661-9
80. Wong WM, Lai KC, Hui WM, et al. Double-blind, randomized controlled study to assess the effects of lansoprazole 30mg and lansoprazole 15mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004 Feb 15; 19 (4): 455-62
81. Inadomi JM, Jamal R, Murata GH, et al. Step-down management of gastroesophageal reflux disease. Gastroenterology 2001 Nov; 121 (5): 1095-100
82. Bardhan KD. Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003 Mar; 98 (3 Suppl.): S40-8
83. Booth MI, Stratford J, Thompson E, et al. Laparoscopic antireflux surgery in the treatment of the acid-sensitive oesophagus. Br J Surg 2001 Apr; 88 (4): 577-82
84. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001 May 9; 285 (18): 2331-8
85. Finlayson SR, Laycock WS, Birkmeyer JD. National trends in utilization and outcomes of antireflux surgery. Surg Endosc 2003 Jun; 17 (6): 864-7
86. Katada N. Review article: surgical and endoscopic therapy of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 2004 Dec; 20 Suppl. 8: 28-31
87. Takeyama S, Numata A, Nenohi M, et al. Laparoscopic Nissen fundoplication for gastroesophageal reflux disease in Japan. Surg Today 2004; 34 (6): 506-9